Evidence map›Paper›PMID 40971564›Full record

ArticleJournal of medical Internet research2025

The Development and Growth of the English National Real-Time Syndromic Surveillance Program: Key Developments and Lessons Learned From the First Two Decades.

Gillian E Smith, Natalia R Jones, Sally E Harcourt, Sue Smith, Paul Loveridge, Roger A Morbey, Helen E Hughes, Obaghe Edeghere, Daniel Todkill, Sue Ibbotson and 3 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Gillian E SmithReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0000-0002-4257-0568
Natalia R JonesNational Institute for Health and Care Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response, King's College London, London, United Kingdom.ORCID http://orcid.org/0000-0003-4025-2985
Sally E HarcourtReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0000-0002-2278-9642
Sue SmithReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0000-0002-1066-5175
Paul LoveridgeReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0009-0008-2102-9044
Roger A MorbeyReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0000-0001-8543-477X
Helen E HughesReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0000-0002-3664-2983
Obaghe EdeghereReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0000-0002-4275-6338
Daniel TodkillReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0000-0002-4325-4786
Sue IbbotsonHealth Equity and Clinical Governance, Chief Medical Advisor Group, UK Health Security Agency, London, United Kingdom.ORCID http://orcid.org/0009-0002-5485-5429
Duncan CooperNHS Bradford Districts Clinical Commissioning Group, Bradford, United Kingdom.ORCID http://orcid.org/0009-0009-6196-2696
Brian McCloskeyDepartment of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID http://orcid.org/0000-0001-7788-894X
Alex J ElliotReal-time Syndromic Surveillance Team, Chief Medical Advisor Group, UK Health Security Agency, 23 Stephenson Street, Birmingham, B2 4BH, United Kingdom, 41 1212329211.ORCID http://orcid.org/0000-0002-6414-3065

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: Syndromic surveillance now forms an integral part of the surveillance for a wide range of hazards in many countries. Establishing syndromic surveillance systems can be difficult due to the many different sources of data that can be used, cost pressures, the importance of data security, and the presence of different (and rapidly evolving) technologies. Here we describe major points in the development of the UK Health Security Agency English real-time syndromic surveillance service over its first 2 decades (1998 to 2018). We identify the key wider themes that we believe are important in ensuring a sustainable and useful syndromic surveillance service. We conducted semistructured interviews with current members of the UK Health Security Agency syndromic surveillance team who were involved from the earliest stages and previous senior colleagues who were supportive of the syndromic surveillance work during the early phases. For this viewpoint, we partitioned the development of syndromic surveillance in England into 3 time periods: 1998 to 2005 ("the beginnings"); 2006 to 2011 ("the growth phase"); and 2012 to 2018 ("mainstream"). We asked the interviewees for their views about the development of syndromic surveillance, and in particular the main drivers and events, the team and system, and outputs and uses. The results from the interviews highlighted some key themes including the integration of syndromic surveillance into the public health system, creativity, good collaboration and teamwork, leadership and determination to persevere, and agility and the ability to adapt to new threats. Using the results of the discussions and our personal experience of running the syndromic surveillance service from inception and over decades, we constructed a set of recommendations for establishing and running sustainable syndromic surveillance systems. In this age of increased automation, with the ability to transfer data in real-time and to use machine learning and artificial intelligence, we are approaching a "new age of syndromic surveillance." We consider that the focus on the public health questions, relationships, collaboration, leadership, and true teamwork should not be underestimated in the success of and usefulness of real-time syndromic surveillance systems.

Indexed as

Population SurveillanceEnglandHumansUnited Kingdomall hazardEnglandepidemiologyhealth protectioninfectious diseasesyndromic surveillance

Identifiers

PMID40971564
PMCPMC12448257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.